Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Nov
3
2016
USPTO Issues New Guidance on Section 101 Schwegman, Lundberg & Woessner, P.A.
Sep
21
2020
China’s Supreme People’s Procuratorate Amends Prosecution Standards for Criminal Trade Secret Theft Schwegman, Lundberg & Woessner, P.A.
Sep
28
2020
China’s Draft Measures for the Administration of Trademark Agencies Should Further Reduce Trademark Squatting Schwegman, Lundberg & Woessner, P.A.
Sep
5
2014
Australia: Cancer Voices v Myriad Opinion Affirmed Schwegman, Lundberg & Woessner, P.A.
Sep
11
2014
Indefiniteness After The Supreme Court Nautilus Decision – A Very “Delicate Balance” Schwegman, Lundberg & Woessner, P.A.
Nov
9
2020
China’s Blue Sky Intellectual Property Industry Rectification Campaign Shows 45% of Violations are for Trademark Squatting and Less Than Half of TM Agencies Signed a Commitment to Abide by the Law Schwegman, Lundberg & Woessner, P.A.
Nov
14
2020
China Releases Draft Revised Patent Examination Guidelines for Comment Schwegman, Lundberg & Woessner, P.A.
Dec
16
2020
The China National Intellectual Property Administration Releases Guiding Cases for Administrative Enforcement of Intellectual Property Rights Schwegman, Lundberg & Woessner, P.A.
Oct
10
2014
Card Verification v. Citigroup: Software Patent Survives 12(b)(6) Abstract Idea Attack Schwegman, Lundberg & Woessner, P.A.
Jan
20
2021
Top Patentees in China for 2020 Schwegman, Lundberg & Woessner, P.A.
Feb
12
2021
China Issues Draft “Measures Regarding the Regulation of Patent Applications” to Crack Down on ‘Abnormal’ Patent Applications Schwegman, Lundberg & Woessner, P.A.
May
4
2017
Federal Circuit in Helsinn v. Teva Declines Limiting Requirements of “On Sale” Bar Schwegman, Lundberg & Woessner, P.A.
Mar
2
2021
China Remains Top Patent Cooperation Treaty Application Filer in 2020 Schwegman, Lundberg & Woessner, P.A.
Nov
14
2014
Federal Circuit flips on Ultramercial v. WildTangent Schwegman, Lundberg & Woessner, P.A.
Apr
9
2021
Neapco’s Brief in Opposition to AA’s Petition for Cert. Schwegman, Lundberg & Woessner, P.A.
Jun
16
2021
Beijing Intellectual Property Court Affirms Jaguar Land Rover’s Win Against Landwind for Copying Evoque Schwegman, Lundberg & Woessner, P.A.
Jul
14
2021
First Generic Declarations Published on China’s New Patent Linkage System Schwegman, Lundberg & Woessner, P.A.
Aug
1
2021
China’s Supreme People’s Court Rules Utility Model Patent Unenforceable if Corresponding Invention Patent Application Fails to Grants Schwegman, Lundberg & Woessner, P.A.
Aug
29
2021
China’s National Intellectual Property Administration Releases Patent Agency Industry Status Report (2020): Chinese Patent Attorneys File 222 Patent Applications Per Year on Average Schwegman, Lundberg & Woessner, P.A.
Mar
9
2015
Universities Response to Patent “Reform” Legislation Schwegman, Lundberg & Woessner, P.A.
Oct
21
2021
China’s Supreme People’s Court Submits Report to the National People’s Congress on Judicial Work on the People’s Courts in Intellectual Property Schwegman, Lundberg & Woessner, P.A.
Nov
4
2021
China’s Supreme People’s Court Rules Unintentional Short Payment of Annuity Fee Causes Termination of Patent Rights Schwegman, Lundberg & Woessner, P.A.
Apr
7
2011
Google Seeks to Acquire Nortel Patents for $900M Schwegman, Lundberg & Woessner, P.A.
Apr
19
2011
Apple Sues Samsung Over Galaxy Products Schwegman, Lundberg & Woessner, P.A.
Apr
27
2011
The Patent Office Wants Your Ideas for Streamlining Reexamination Schwegman, Lundberg & Woessner, P.A.
Dec
29
2021
Biogen v. Mylan – Therapeutic v. Clinical Efficacy – What is Required by the Written Description Requirement? Schwegman, Lundberg & Woessner, P.A.
May
25
2011
Patent Owner Stay Motion Successful Based on Defendants’ Reexam Requests Filed on Eve of Markman Schwegman, Lundberg & Woessner, P.A.
Jan
25
2022
China Releases 2022 National Intellectual Property Administrative Protection Work Plan Schwegman, Lundberg & Woessner, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins